First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes
详细信息 查看全文
- 作者：Otavio Cabral-Marques (1)
Stefanie Klaver (1)
Lena F Schimke (1)
évelyn H Ascendino (1)
Taj Ali Khan (1)
Paulo Vítor Soeiro Pereira (1)
Angela Falcai (1)
Alexander Vargas-Hernández (2)
Leopoldo Santos-Argumedo (2)
Liliana Bezrodnik (3)
Ileana Moreira (3)
Gisela Seminario (3)
Daniela Di Giovanni (3)
Andrea Gómez Raccio (3)
Oscar Porras (4)
Cristina Worm Weber (5)
Janaíra Fernandes Ferreira (6)
Fabiola Scancetti Tavares (7)
Elisa de Carvalho (7)
Claudia Fran?a Cavalcante Valente (7)
Gisele Kuntze (8)
Miguel Galicchio (9)
Alejandra King (10)
Nelson Augusto Rosário-Filho (11)
Milena Baptistella Grota (12)
Maria Marluce dos Santos Vilela (12)
Regina Sumiko Watanabe Di Gesu (13)
Simone Lima (14)
Leiva de Souza Moura (14)
Eduardo Talesnik (15)
Eli Mansour (16)
Pérsio Roxo-Junior (17)
Juan Carlos Aldave (18)
Ekaterine Goudouris (19)
Fernanda Pinto-Mariz (19)
Laura Berrón-Ruiz (20)
Tamara Staines-Boone (21)
Wilmer O. Córdova Calderón (22)
María del Carmen Zarate-Hernández (23)
Anete S. Grumach (24)
Ricardo Sorensen (25)
Anne Durandy (26)
Troy R. Torgerson (27)
Beatriz Tavares Costa Carvalho (28)
Francisco Espinosa-Rosales (20)
Hans D. Ochs (27)
Antonio Condino-Neto (1) - 关键词：Latin American Society for Immunodeficiencies ; Hyper ; IgM syndrome ; CD40L deficiency ; AID deficiency ; infections ; mutations
- 刊名：Journal of Clinical Immunology
- 出版年：2014
- 出版时间：February 2014
- 年：2014
- 卷：34
- 期：2
- 页码：146-156
- 全文大小：421 KB
- 参考文献：1. Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3(2):101-1.
2. Burtin P. An example of atypical agammaglobulinemia (a case of severe hypogammaglobulinemia with increase of the beta-2 macroglobulin. Rev Fr Etud Clin Biol. 1961;6:286-.
3. Israel-Asselain R, Burtin P, Chebat J. A new biological disorder: agammaglobulinemia with beta2-macroglobulinemia (a case). Bull Mem Soc Med Hop Paris. 1960;76:519-3.
4. Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D. Dysgammaglobulinaemia and recurrent bacterial infection. Lancet. 1961;1(7179):700. CrossRef
5. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259(5097):990-. CrossRef
6. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72(2):291-00. CrossRef
7. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint BG. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature. 1993;361(6412):541-. CrossRef
8. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90(6):2170-. CrossRef
9. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361(6412):539-1. CrossRef
10. Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27(3):277-5. CrossRef
11. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2(3):223-. CrossRef
12. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102(5):565-5. CrossRef
13. Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol. 2003;4(10):1023-. CrossRef
14. Peron S, Metin A, Gardes P, Alyanakian MA, Sheridan E, Kratz CP, et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med. 2008;205(11):2465-2. CrossRef
15. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881-0. CrossRef
16. Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol. 2006;117(4):855-4. CrossRef
17. Cabral-Marques O, Arslanian C, Ramos RN, Morato M, Schimke L, Soeiro Pereira PV, et al. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis. J Allergy Clin Immunol. 2012;129(3):778-6. CrossRef
18. Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest. 1999;103(8):1151-. CrossRef
19. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82(6):373-4. CrossRef
20. Cabral-Marques O, Schimke LF, Pereira PV, Falcai A, de Oliveira JB, Hackett MJ, et al. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients. J Clin Immunol. 2012;32(2):212-0. CrossRef
21. Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol. 2004;110(1):22-. CrossRef
22. Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92(7):2421-4.
23. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15(1):7-2. CrossRef
24. Taschner PE, den Dunnen JT. Describing structural changes by extending HGVS sequence variation nomenclature. Hum Mutat. 2011;32(5):507-1. CrossRef
25. Danielian S, Oleastro M, Eva Rivas M, Cantisano C, Zelazko M. Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called “milder-mutants. J Clin Immunol. 2007;27(4):455-. CrossRef
26. Vargas-Hernandez A, Berron-Ruiz L, Staines-Boone T, Zarate-Hernandez M, Cordova-Calderon W, Espinosa-Rosales F, et al. Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome. Clin Genet. 2012 Sep 10.
27. Lin Q, Rohrer J, Allen RC, Larche M, Greene JM, Shigeoka AO, et al. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest. 1996;97(1):196-01. CrossRef
28. Macchi P, Villa A, Strina D, Sacco MG, Morali F, Brugnoni D, et al. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet. 1995;56(4):898-06.
29. Prasad ML, Velickovic M, Weston SA, Benson EM. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives. J Clin Pathol. 2005;58(1):90-. CrossRef
30. Mu Y, Prochnow C, Pham P, Chen XS, Goodman MF. A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants. J Biol Chem. 2012;287(33):28007-6. CrossRef
31. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1 Pt 1):47-4. CrossRef
32. Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97(3):203-0. CrossRef
33. Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. 2001;98(22):12614-. CrossRef
34. Condino-Neto A, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, Porras O, et al. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives. Allergol Immunopathol (Madr). 2012;40(3):187-3. CrossRef
35. Condino-Neto A, Franco JL, Trujillo-Vargas C, Espinosa-Rosales FJ, Leiva LE, Rodriguez-Quiroz F, et al. Critical issues and needs in management of primary immunodeficiency diseases in Latin America. Allergol Immunopathol (Madr). 2011;39(1):45-1. CrossRef
36. Durandy A, Revy P, Fischer A. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv Immunol. 2004;82:295-30. CrossRef
37. Erdos M, Lakos G, Derfalvi B, Notarangelo LD, Durandy A, Marodi L. Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome. Mol Immunol. 2008;45(1):278-2. CrossRef
38. Krones E, Hogenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am. 2012;41(3):677-01. CrossRef
39. Ben-Ari J, Wolach O, Gavrieli R, Wolach B. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression. Expert Rev Anti Infect Ther. 2012;10(8):881-4. CrossRef
40. Foy HM, Ochs H, Davis SD, Kenny GE, Luce RR. Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis. 1973;127(4):388-3. CrossRef
41. Gelfand EW. Unique susceptibility of patients with antibody deficiency to mycoplasma infection. Clin Infect Dis. 1993;17 Suppl 1:S250-.
42. Henriet SS, Verweij PE, Warris A. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction. J Infect Dis. 2012;206(7):1128-7. CrossRef
43. Marcinkowski M, Bauer K, Stoltenburg-Didinger G, Vogel M, Versmold H. Fatal aspergillosis with brain abscesses in a neonate with DiGeorge syndrome. Pediatr Infect Dis J. 2000;19(12):1214-. CrossRef
44. Silva GB, Fernandes KP, Segundo GR. Common variable immunodeficiency and isosporiasis: first report case. Rev Soc Bras Med Trop. 45(6):768-.
45. Wolach B, Eliakim A, Gottesman G, Yellin A. Pulmonary aspergillosis in a child with hyperimmunoglobulin E syndrome. Clin Infect Dis. 1998;26(1):204-. CrossRef
46. Yoshihara T, Morimoto A, Nakauchi S, Fujii N, Tsunamoto K, Misawa A, et al. Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with aspergillus pneumonia. Pediatr Hematol Oncol. 2002;19(6):439-3. CrossRef
47. Subauste CS, Wessendarp M, Sorensen RU, Leiva LE. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol. 1999;162(11):6690-00.
48. Fontana S, Moratto D, Mangal S, De Francesco M, Vermi W, Ferrari S, et al. Functional defects of dendritic cells in patients with CD40 deficiency. Blood. 2003;102(12):4099-06. CrossRef
49. Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis. 1998;178(2):318-4. CrossRef
50. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16):1617-4. CrossRef
51. Guerra-Maranhao MC, Costa-Carvalho BT, Nudelman V, Barros-Nunes P, Carneiro-Sampaio MM, Arslanian C, et al. Response to polysaccharide antigens in patients with ataxia-telangiectasia. J Pediatr (Rio J). 2006;82(2):132-. - 作者单位：Otavio Cabral-Marques (1)
Stefanie Klaver (1)
Lena F Schimke (1)
évelyn H Ascendino (1)
Taj Ali Khan (1)
Paulo Vítor Soeiro Pereira (1)
Angela Falcai (1)
Alexander Vargas-Hernández (2)
Leopoldo Santos-Argumedo (2)
Liliana Bezrodnik (3)
Ileana Moreira (3)
Gisela Seminario (3)
Daniela Di Giovanni (3)
Andrea Gómez Raccio (3)
Oscar Porras (4)
Cristina Worm Weber (5)
Janaíra Fernandes Ferreira (6)
Fabiola Scancetti Tavares (7)
Elisa de Carvalho (7)
Claudia Fran?a Cavalcante Valente (7)
Gisele Kuntze (8)
Miguel Galicchio (9)
Alejandra King (10)
Nelson Augusto Rosário-Filho (11)
Milena Baptistella Grota (12)
Maria Marluce dos Santos Vilela (12)
Regina Sumiko Watanabe Di Gesu (13)
Simone Lima (14)
Leiva de Souza Moura (14)
Eduardo Talesnik (15)
Eli Mansour (16)
Pérsio Roxo-Junior (17)
Juan Carlos Aldave (18)
Ekaterine Goudouris (19)
Fernanda Pinto-Mariz (19)
Laura Berrón-Ruiz (20)
Tamara Staines-Boone (21)
Wilmer O. Córdova Calderón (22)
María del Carmen Zarate-Hernández (23)
Anete S. Grumach (24)
Ricardo Sorensen (25)
Anne Durandy (26)
Troy R. Torgerson (27)
Beatriz Tavares Costa Carvalho (28)
Francisco Espinosa-Rosales (20)
Hans D. Ochs (27)
Antonio Condino-Neto (1)
1. Department of Immunology, Institute of Biomedical Sciences, University of S?o Paulo, 1730 Lineu Prestes Avenue, S?o Paulo, SP, ZIP 05508-000, Brazil
2. Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados-IPN, Zacatenco, México, D.F, México
3. Dr. Ricardo Gutierrez Children’s Hospital, Immunology, Buenos Aires, Argentina
4. Hospital Nacional de Ni?os, “Dr. Carlos Sáenz Herrera- San Jose, Costa Rica
5. Pediatric Allergy & Immunology Clinic, Caxias do Sul, RS, Brazil
6. Albert Sabin Hospital, Fortaleza, CE, Brazil
7. Pediatric Immunology Clínic, Hospital de Base do Distrito Federal, Brasilia, DF, Brazil
8. Integrated Center of Pediatric Specialties, Curitiba, PR, Brazil
9. Hospital de Ni?os V. J. Vilela, Rosario, Argentina
10. Hospital Luis Calvo Mackenna, Santiago, Chile
11. Department of Pediatrics, Federal University of Paraná, Curitiba, PR, Brazil
12. Department of Pediatrics, State University of Campinas Medical School, Campinas, SP, Brazil
13. Division of Allergy and Immunolgy, Department of Pediatrics, Concei??o Children’s Hospital, Porto Alegre, RS, Brazil
14. Childrens Hospital Lucídio Portela, Teresina, PI, Brazil
15. Division of Pediatrics, Pontificia Universidad Católica de Chile, Santiago, Chile
16. Department of Medicine, State University of Campinas Medical School, Campinas, SP, Brazil
17. Ribeir?o Preto Medical School, University of S?o Paulo, Ribeir?o Preto, SP, Brazil
18. Hospital Nacional Edgardo Rebagliati Martins-Alergia e Inmunologia, Lima, Peru
19. Department of Pediatrics, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
20. Unidad de Investigación en Inmunodeficiencias, Instituto Nacional de Pediatría, México, D.F, Mexico
21. Unidad Médica de Alta Especialidad #25, IMSS, Monterrey, Nuevo León, México
22. Unidad de Inmunología, Clínica Montefiori, Lima, Perú
23. Hospital Universitario, U.A.N.L, Monterrey, Nuevo León, México
24. Faculty of Medicine ABC, Santo André, SP, Brazil
25. Department of Pediatrics, Children’s Hospital, New Orleans, LA, USA
26. INSERM, Unité U768, H?pital Necker Enfants-Malades, Paris, France
27. Department of Pediatrics, University of Washington School of Medicine, and Seattle Children’s Research Institute, Seattle, WA, USA
28. Division of Allergy-Immunology and Rheumatology, Department of Pediatrics, Federal University of S?o Paulo, S?o Paulo, Brazil - ISSN：1573-2592
文摘
Hyper-IgM (HIGM) syndrome is a heterogeneous group of disorders characterized by normal or elevated serum IgM levels associated with absent or decreased IgG, IgA and IgE. Here we summarize data from the HIGM syndrome Registry of the Latin American Society for Immunodeficiencies (LASID). Of the 58 patients from 51 families reported to the registry with the clinical phenotype of HIGM syndrome, molecular defects were identified in 37 patients thus far. We retrospectively analyzed the clinical, immunological and molecular data from these 37 patients. CD40 ligand (CD40L) deficiency was found in 35 patients from 25 families and activation-induced cytidine deaminase (AID) deficiency in 2 unrelated patients. Five previously unreported mutations were identified in the CD40L gene (CD40LG). Respiratory tract infections, mainly pneumonia, were the most frequent clinical manifestation. Previously undescribed fungal and opportunistic infections were observed in CD40L-deficient patients but not in the two patients with AID deficiency. These include the first cases of pneumonia caused by Mycoplasma pneumoniae, Serratia marcescens or Aspergillus sp. and diarrhea caused by Microsporidium sp. or Isospora belli. Except for four CD40L-deficient patients who died from complications of presumptive central nervous system infections or sepsis, all patients reported in this study are alive. Four CD40L-deficient patients underwent successful bone marrow transplantation. This report characterizes the clinical and genetic spectrum of HIGM syndrome in Latin America and expands the understanding of the genotype and phenotype of this syndrome in tropical areas.